Serum selenium and selenoprotein P in patients with silicosis

Journal of Trace Elements in Medicine and Biology

Volumn 27, Issue 1, 2013, Pages 40-44

  Muzembo, Basilua Andre ^a   Dumavibhat, Narongpon ^a   Ngatu, N'landu Roger ^a   Eitoku, Masamitsu ^a   Hirota, Ryoji ^a   Kondo, Shinichi ^b   Deguchi, Yoji ^c   Saito, Yoshiro ^d   Takahashi, Kazuhiko ^e   Suganuma, Narufumi ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Kochi Prefecture   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d DOSHISHA UNIVERSITY   (Japan)

^e HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Case control study; Serum selenium; Serum selenoprotein P; Silicosis

Indexed keywords

SELENIUM; SELENOPROTEIN P;

ADULT; AGED; ANAMNESIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; HUMAN; JAPAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SILICOSIS; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; SELENIUM; SELENOPROTEIN P; SILICOSIS;

EID: 84872395056     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.05.003     Document Type: Article

References (37)

1. Fubini B., Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 2003, 34:1507-1516.
2. Rimal B., Greenberg A.K., Rom W.N. Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med 2005, 11:169-173.
3. Pelclova D., Fenclova Z., Kacer P., Navratil T., Kuzma M., Lebedova J.K., et al. 8-Isoprostane and leukotrienes in exhaled breath condensate in Czech subjects with silicosis. Ind Health 2007, 45:766-774.
4. Silica, some silicates, coal dust and para-Aramid-Fibrills (1997) IARC monographs on the evaluation of carcinogenic risks of chemicals to humans 1997, IARC, Lyon. IARC (Ed.).
5. Tsuda T., Mino Y., Babazono A., Shigemi J., Otsu T., Yamamoto E., et al. A case-control study of lung cancer in relation to silica exposure and silicosis in a rural area in Japan. Ann Epidemiol 2002, 12:288-294.
6. Klaunig J.E., Wang Z., Pu X., Zhou S. Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol 2011, 254:86-99.
7. Dennert G., Zwahlen M., Brinkman M., Vinceti M., Zeegers M.P., Horneber M. Selenium for preventing cancer. Cochrane Database Syst Rev 2011, 5:CD005195.
8. Epplein M., Franke A.A., Cooney R.V., Morris J.S., Wilkens L.R., Goodman M.T., et al. Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009, 18:1962-1970.
9. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996, 276:1957-1963.
10. Fritz H., Kennedy D., Fergusson D., Fernandes R., Cooley K., Seely A., et al. Selenium and lung cancer: a systematic review and meta analysis. PLoS One 2011, 6:e26259.
11. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
12. Combs G.F. Selenium in global food systems. Br J Nutr 2001, 85:517-547.
13. Stratton M.S., Reid M.E., Schwartzberg G., Minter F.E., Monroe B.K., Alberts D.S., et al. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study. Anticancer Drugs 2003, 14:595-600.
14. Burk R.F., Hill K.E., Selenoprotein P. an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005, 25:215-235.
15. Lu J., Holmgren A. Selenoproteins. J Biol Chem 2009, 284:723-727.
16. Hollenbach B., Morgenthaler N.G., Struck J., Alonso C., Bergmann A., Kohrle J., et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008, 22:24-32.
17. Moschos M.P., Selenoprotein P. Cell Mol Life Sci 2000, 57:1836-1845.
18. Schweizer U., Streckfuss F., Pelt P., Carlson B.A., Hatfield D.L., Kohrle J., et al. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem J 2005, 386:221-226.
19. Xia Y., Hill K.E., Li P., Xu J., Zhou D., Motly A.K., et al. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr 2010, 92:525-531.
20. Ge K., Xue A., Bai J., Wang S. Keshan disease - an endemic cardiomyopathy in China. Virchows Arch A Pathol Anat Histopathol 1983, 401:1-15.
21. Van L.M., West C.E., Van der Meer J.W., Wieringa F.T., Semba R.D. Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukine-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi. Eur J Clin Nutr 2005, 59:526-532.
22. Gottschall E.B., Wolfe P., Haegele A.D., Zhu Z., Rose C.S., Sells T., et al. Increased urinary 8-isoprostaglandin F(2)alpha is associated with lower plasma selenium levels and lower vegetable and fruit intake in an asbestos-exposed cohort at risk for lung cancer. Chest 2004, 12:83S.
23. Nadif R., Oryszczyn M.P., Fradier-Dusch M., Hellier G., Bertrand J.P., Pham Q.T., et al. Cross sectional and longitudinal study on selenium, glutathione peroxidase, smoking, and occupational exposure in coal miners. Occup Environ Med 2001, 58:239-245.
24. Yoneyama S., Miura K., Itai K., Yoshita K., Nakagawa H., Shimmura T., et al. Dietary intake and urinary excretion of selenium in the Japanese adult population: the INTERMAP Study Japan. Eur J Clin Nutr 2008, 62:1187-1193.
25. Kusaka Y., Morimoto K. A pilot study to evaluate Japanese standard radiographs of pneumoconioses (1982) according to the ILO 1980 International Classification of Radiographs of Pneumoconioses. Ann Occup Hyg 1992, 36:425-431.
26. Wang H. Determination of beryllium and selenium in human urine and selenium in human serum graphite-furnace atomic absorption spectrometry. Anal Sci 2001, 17:527-532.
27. Saito Y., Watanabe Y., Saito E., Honjoh T., Takahashi K. Production and application of monoclonal antibodies to human selenoprotein P. J Health Sci 2001, 47:346.
28. Rasmussen L.B., Hollenbach B., Laurberg P., Carle A., Hog A., Jorgensen T., et al. Serum selenium and selenoprotein P status in adult Danes - 8-year followup. J Trace Elem Med Biol 2009, 23:265-271.
29. Neve J. Methods in determination of selenium states. J Trace Elem Elect Health Dis 1991, 5:1-17.
30. Thomson C.D., Robinson M.F., Butler J.A., Whanger P.D. Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women. Br J Nutr 1993, 69:577-588.
31. Matsuda A., Kimura M., Itokawa Y. Selenium level and glutathione peroxidase activity in plasma, erythrocytes and platelets of healthy Japanese volunteers. J Nutr Sci Vitaminol 1997, 43:497-504.
32. Hesse-Bahr K., Dreher I., Kohrle J. The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2. Biofactors 2000, 11:83-85.
33. Takemoto A.S., Berry M.J., Bellinger F.P. Role of selenoprotein P in Alzheimer's disease. Ethn Dis 2010, 20:S1-S92.
34. Coudray C., Roussel A.M., Mainard F., Arnaud J., Favier A. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr 1997, 16:584-591.
35. Jablonska E., Gromadzinska J., Sobala W., Reszka E., Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr 2008, 47:47-54.
36. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
37. Bleys J., Navas-Acien A., Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 2008, 168:404-410.